> ## Content Index
> Fetch the complete content index at: https://www.duethedilly.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# The Dime💰- Oura Farming
- URL: https://www.duethedilly.com/the-dime-7/
- Published: 2026-09-05T21:41:36.000Z
- Updated: 2026-09-05T21:41:36.000Z
- Description: "If it's a lie, then we fight on that lie, but we gotta fight." - Slim Charles
- Author: Carl Joseph-Black
- Tags: The Dime

The first thing I do when I wake up in the morning is check my sleep score on Oura app. It's a habit I developed in the last year since a friend of mine gifted me an Oura ring. Prior to that I only knew how to communicate my sleep based on how I felt. I'm assuming, for millions of people, that is now the same. That's the business Oura built, and on August 20th a proposed class action filed in the Northern District of California argued that the number is closer to a guess than a measurement, **and that Oura knew it**.

The case is *Surber v. Oura Inc.*, filed by the Clarkson Law Firm, the same shop behind a long run of consumer class actions against companies that make specific, quantified claims about what their products can do. Madison Surber bought an Oura Ring 4 Gold for $513.68 in May 2025\. She says she bought it because Oura told her the ring could track her sleep stages accurately, and that if she'd known it couldn't, she wouldn't have paid what she paid, or paid at all.

Quick intro if you're new here. I'm Carl, by day I run Joseph Black Law PLLC, a New York law practice where I work on startup and venture capital transactions, entertainment, music deals, and investment fund structures. By night, and honestly during a lot of stolen lunch hours, I write The Dime💰.

The Dime💰 exists for one reason: the most interesting financial stories in America run through culture, and almost nobody covers them with both the spreadsheet and the source material open at the same time. The music press covers the artist. The financial press covers the companies. The Dime💰 covers the deals.

Let's start with what Oura actually said, because the specificity here is the whole case. Here's this week's edition of The Dime💰.

## **The claims, in their own words**

[oura lawsuitoura lawsuit.pdf2 MBdownload-circle](https://www.duethedilly.com/content/files/2026/09/oura-lawsuit.pdf "Download")

Oura's marketing made numbers up front and center: "79% agreement with gold-standard polysomnography," and, more recently, "95% Sleep Staging Accuracy compared to clinical sleep lab." Add to that "built for accuracy," "unparalleled accuracy," and language describing the ring as an "alternative to PSG sleep studies," PSG being polysomnography, the lab-based sleep study that's the actual clinical standard.

That standard matters here, so walk through it with me for a second. A polysomnography study measures brain electrical activity through electrodes on your scalp, eye movement through leads near your eyes, and muscle tone through sensors on your chin. REM sleep, the stage most people care about most, is defined by rapid eye movement. Deep sleep is defined by a specific frequency of brain wave, 0.5 to 2.0 Hz at a minimum amplitude, present in at least 20% of a 30 second window. None of that is optional or approximate. It's how sleep stages are clinically defined.

An Oura ring measures none of it. It measures heart rate, heart rate variability, skin temperature, movement, and in newer models, blood oxygen. Then a proprietary algorithm infers what stage of sleep you're probably in based on those signals. It's not the same thing as measuring the thing itself, the way checking whether your neighbor's porch light is on tells you something about whether they're home, but it's not the same as opening their door and looking.

## **The number that should worry Oura's lawyers**

Here's where the complaint gets its teeth. A Nature-published study tracking 45 patients over 45 nights found Oura's sleep staging came in at 53.18% accuracy against actual polysomnography, not 79%, not 95%. A separate University of Massachusetts study found the same gap, worse in older adults. Even Oura's own self-funded validation study, buried in its technical documentation rather than its marketing, admits the product overestimates light sleep under certain durations and underestimates it under others, same story for deep sleep. The complaint's phrase for what a consumer is actually getting for that 79-95% promise: "a coin flip's chance of being correct."

That gap between the marketing number and the real number is the entire lawsuit. And it points to something every founder reading this newsletter should understand cold, because I see it in contracts and pitch decks constantly. There's a legal difference between puffery and an actionable representation, and that difference lives almost entirely in whether you attached a number to it.

## **Puffery versus a number, and why it's not a technicality**

"Built for accuracy" is the kind of statement courts have historically treated as puffery, vague, subjective, not the sort of thing a reasonable consumer relies on as a factual promise. Companies say things like that constantly and mostly get away with it. "95% Sleep Staging Accuracy compared to clinical sleep lab" is a different animal entirely. That's a specific, falsifiable, measurable claim. You can test it. Clarkson's firm apparently did, or at least found the studies that did. Once you put a percentage next to a comparison to a named clinical standard, you've made a factual representation the FTC and California's consumer protection statutes can hold you to, not an opinion you can shrug off in a deposition.

This is why the complaint stacks so many causes of action on the same underlying facts: fraud by misrepresentation, unjust enrichment, all three prongs of California's Unfair Competition Law (unlawful, unfair, and fraudulent, each requiring its own proof but all fed by the same set of marketing statements), the False Advertising Law, the Consumers Legal Remedies Act, and breach of both express and implied warranty under the Song-Beverly Act. Seven causes of action, one underlying fact pattern: a specific, quantified, testable claim that independent researchers say wasn't true.

## **Why this matters beyond Oura**

Oura is an $11 billion company that sold nearly 3 million rings in 2025 alone, more than a billion dollars in revenue. That kind of scale is exactly what makes a plaintiff's firm confident about class certification, thousands of purchasers, one uniform set of marketing claims used across every unit sold. But the legal exposure here isn't really about Oura's size. It's about the decision, somewhere in a marketing meeting, to put "95%" on a product page instead of leaving it at "clinically informed" or "built with sleep science." That one word choice is the difference between a defensible brand claim and a seven count complaint.

If you're building a health or wellness product and your team wants to quantify a performance claim, ask the question this lawsuit answers for you for free: do you have independent, peer-reviewed validation for that exact number, not just your own internal study, and are you willing to defend it against whatever a plaintiff's expert finds in the literature. If the answer is no, the marketing team needs to hear that before the lawyers do, because by the time the lawyers hear about it, it usually looks like this complaint.

Oura hasn't answered yet. When they do, expect the fight to center on exactly this line between opinion and fact, and on whether "compared to clinical sleep lab" was ever a claim a reasonable consumer should have taken literally. I'll be watching the docket. That's it for this week's edition of The Dime💰. Don't be stingy with the 🏀. Pass this to a friend. 

See y'all next week.

CJB